These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 8538848

  • 21. Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study.
    Nielsen CB, Bech JN, Pedersen EB.
    Br J Clin Pharmacol; 1997 Nov; 44(5):471-6. PubMed ID: 9384464
    [Abstract] [Full Text] [Related]

  • 22. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
    Silberbach M, Woods LL, Hohimer AR, Shiota T, Matsuda Y, Davis LE.
    Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
    [Abstract] [Full Text] [Related]

  • 23. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
    Abraham WT, Lauwaars ME, Kim JK, Peña RL, Schrier RW.
    Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
    [Abstract] [Full Text] [Related]

  • 24. Effect of potassium supplementation on renal tubular function, ambulatory blood pressure and pulse wave velocity in healthy humans.
    Matthesen SK, Larsen T, Vase H, Lauridsen TG, Pedersen EB.
    Scand J Clin Lab Invest; 2012 Feb; 72(1):78-86. PubMed ID: 22149452
    [Abstract] [Full Text] [Related]

  • 25. Abnormal tubular handling of sodium and water induced by atrial natriuretic peptide in essential hypertension.
    Eiskjaer H, Jensen JD, Jespersen B, Sørensen SS, Pedersen EB.
    J Intern Med; 1991 Jul; 230(1):37-48. PubMed ID: 1829753
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
    Rousso P, Buclin T, Nussberger J, Décosterd LA, La Roche SD, Brunner-Ferber F, Brunner HR, Biollaz J.
    J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
    [Abstract] [Full Text] [Related]

  • 30. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A, Ceolotto G, Sartori M, Maresca A, Baritono E, De Toni R, Paparella I, Calò L.
    J Nephrol; 2002 Mar; 15(5):489-96. PubMed ID: 12455714
    [Abstract] [Full Text] [Related]

  • 31. Increased atrial natriuretic peptide in the nephrotic syndrome. Relationship to the renal function and the renin-angiotensin-aldosterone system.
    Pedersen EB, Danielsen H, Eiskjaer H, Jespersen B, Sørensen SS.
    Scand J Clin Lab Invest; 1988 Apr; 48(2):141-7. PubMed ID: 2965826
    [Abstract] [Full Text] [Related]

  • 32. Increased atrial natriuretic peptide in an early stage of chronic glomerulonephritis.
    Sørensen SS, Danielsen H, Pedersen EB.
    Scand J Clin Lab Invest; 1988 Jun; 48(4):347-55. PubMed ID: 2976977
    [Abstract] [Full Text] [Related]

  • 33. Enhanced renal production of cyclic GMP and reduced free water clearance during sodium nitroprusside infusion in healthy man.
    Nielsen CB, Eiskjaer H, Pedersen EB.
    Eur J Clin Invest; 1993 Jun; 23(6):375-81. PubMed ID: 8393795
    [Abstract] [Full Text] [Related]

  • 34. Atrial natriuretic peptide and renal adaptation to contralateral nephrectomy in healthy man.
    Kamper AL, Pedersen EB, Strandgaard S, Holstein-Rathlou NH, Leyssac PP, Skaarup P, Hemmingsen L, Holm J, Munck O.
    Scand J Clin Lab Invest; 1991 Feb; 51(1):99-103. PubMed ID: 1826969
    [Abstract] [Full Text] [Related]

  • 35. Renal interaction of atrial natriuretic peptide with angiotensin II: glomerular and tubular effects.
    Rakugi H, Ogihara T, Nakamaru M, Saito H, Shima J, Sakaguchi K, Kumahara Y.
    Clin Exp Pharmacol Physiol; 1989 Feb; 16(2):97-107. PubMed ID: 2523767
    [Abstract] [Full Text] [Related]

  • 36. Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man.
    Eiskjaer H, Bagger JP, Danielsen H, Jensen JD, Jespersen B, Thomsen K, Pedersen EB.
    Int J Cardiol; 1991 Oct; 33(1):61-74. PubMed ID: 1657800
    [Abstract] [Full Text] [Related]

  • 37. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ, Espiner EA, Nicholls MG, Richards AM, Yandle TG.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
    [Abstract] [Full Text] [Related]

  • 38. Interaction of ANP with endothelin on cardiovascular, renal, and endocrine function.
    Ota K, Kimura T, Shoji M, Inoue M, Sato K, Ohta M, Yamamoto T, Tsunoda K, Abe K, Yoshinaga K.
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E135-41. PubMed ID: 1531732
    [Abstract] [Full Text] [Related]

  • 39. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
    Beutler JJ, Koomans HA, Bijlsma JA, Dorhout Mees EJ.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1314-9. PubMed ID: 2148189
    [Abstract] [Full Text] [Related]

  • 40. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW, Canepa-Anson R, Armstrong PW.
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.